as 11-15-2024 12:34pm EST
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
Founded: | 1954 | Country: | United States |
Employees: | N/A | City: | GREENFIELD |
Market Cap: | 6.3B | IPO Year: | 2018 |
Target Price: | $17.00 | AVG Volume (30 days): | 4.7M |
Analyst Decision: | Buy | Number of Analysts: | 6 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.41 | EPS Growth: | N/A |
52 Week Low/High: | $11.20 - $18.80 | Next Earning Date: | 11-07-2024 |
Revenue: | $4,454,000,000 | Revenue Growth: | 1.99% |
Revenue Growth (this year): | 2.22% | Revenue Growth (next year): | 2.77% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Harrington Michael J | ELAN | Director | Aug 22 '24 | Buy | $14.85 | 3,500 | $51,974.30 | 81,094 |
ELAN Breaking Stock News: Dive into ELAN Ticker-Specific Updates for Smart Investing
Simply Wall St.
5 hours ago
MT Newswires
3 days ago
Simply Wall St.
3 days ago
MT Newswires
3 days ago
MT Newswires
3 days ago
The Wall Street Journal
3 days ago
PR Newswire
3 days ago
Simply Wall St.
5 days ago
The information presented on this page, "ELAN Elanco Animal Health Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.